Design Therapeutics, Inc. (DSGN) Net income 2020–2025
Design Therapeutics, Inc. (DSGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$69.8MFY2025 · since FY2020: -$8.3M → -$69.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$69.8M | -40.7% |
| FY2024 | -$49.6M | +25.8% |
| FY2023 | -$66.9M | -5.6% |
| FY2022 | -$63.3M | -78.2% |
| FY2021 | -$35.5M | -329.1% |
| FY2020 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DSGN financial trends
DSGN RevenueDSGN Net marginDSGN Gross profitDSGN Gross marginDSGN Operating incomeDSGN Operating marginDSGN Operating cash flowDSGN Free cash flowDSGN Capital expendituresDSGN Return on equityDSGN Stock buybacksDSGN Dividends paidDSGN Total assetsDSGN Total liabilitiesDSGN Shareholders’ equityDSGN overview →